The aptamers market encompasses the subset of the biotechnology and pharmaceutical industries that design and utilize aptamers for use in research and diagnostics tools. Diagnostics, therapeutic intervention, and research uses aptamers because these molecules replicate the antigen binding properties of antibodies without drawbacks of antibody use, which include cost, instability, and lack of ease in their modification.

The IPV (Inactivated Poliovirus) Vaccines Market pertains to the global manufacture, distribution and supply of vaccines that are comprised from a weakened inactivated poliovirus and are administered with the purpose of providing immunization to poliomyelitis. While the OPV still developed from a live virus that could cause polio, IPV vaccines contain killed virus meaning that they are safe for immunocompromised persons. They are usually in the form of injection and they form part of efforts being made around the world to eliminate poliomyelitis and their demand emanates from governmental immunization programs, health care facilities and public health organizations.

Animal biotechnology industry or animal biotechnology market therefore refers to any biotechnological uses and processes or technologies with a focus on enhancing animal health, production and well-being. It incorporates genetic technologies, diagnostics, or reproductive biotechnologies for improved stock breeding, vaccine or therapeutic production and generally the quality of animal products.

Downstream processing is the process of harvesting and purifying biosynthetic products such as; proteins and antibodies from natural sources or a biological manufacturing process. They embody various phases as the process of separation, purification, and formulation of the compound to reach the final stage of commercial readiness.